Treatment of cancer radiotherapy dosage. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Organs at Risk Cell Line, Tumor Pelvis Breast Neoplastic Stem Cells Prostate Tumor Cells, Cultured Lymph Nodes

Organisms1

Diseases66

Radiodermatitis Radiation Injuries Prostatic Neoplasms Breast Neoplasms Lung Neoplasms Neoplasm Recurrence, Local Head and Neck Neoplasms Carcinoma, Squamous Cell Neoplasms Rectal Neoplasms Brain Neoplasms Neoplasm Metastasis Uterine Cervical Neoplasms Nasopharyngeal Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma Ovarian Neoplasms Neoplasm Invasiveness Stomach Neoplasms Neoplasms, Radiation-Induced Pancreatic Neoplasms Colonic Neoplasms Neoplasms, Second Primary Adenocarcinoma Esophageal Neoplasms Disease Progression Radiation Pneumonitis Pelvic Neoplasms Urinary Bladder Neoplasms Hodgkin Disease Bone Neoplasms Laryngeal Neoplasms Carcinoma, Small Cell Xerostomia Genetic Predisposition to Disease Colorectal Neoplasms Endometrial Neoplasms Glioblastoma Liver Neoplasms Mouth Neoplasms Genital Neoplasms, Female Spinal Neoplasms Oropharyngeal Neoplasms Pharyngeal Neoplasms Testicular Neoplasms Glioma Skin Neoplasms Sarcoma Thoracic Neoplasms Cell Transformation, Neoplastic Hypopharyngeal Neoplasms Neoplasms, Multiple Primary Osteoradionecrosis Neovascularization, Pathologic Gastrointestinal Neoplasms Recurrence Melanoma Lymphatic Metastasis Anus Neoplasms Stomatitis Thyroid Neoplasms Nose Neoplasms Small Cell Lung Carcinoma Neoplasms, Hormone-Dependent Mucositis Fatigue

Chemicals and Drugs50

Cisplatin Antineoplastic Agents Fluorouracil Radiation-Sensitizing Agents Dosage Forms Prostate-Specific Antigen Tumor Markers, Biological Cancer Vaccines Neoplasm Proteins Vincristine Dacarbazine Androgen Antagonists Antineoplastic Agents, Hormonal Cyclophosphamide Procarbazine Antimetabolites, Antineoplastic Deoxycytidine Antineoplastic Agents, Phytogenic Receptors, Estrogen Vinblastine RNA, Messenger Tumor Suppressor Protein p53 Paclitaxel Antineoplastic Agents, Alkylating Cobalt Radioisotopes Radiopharmaceuticals Receptor, erbB-2 DNA, Neoplasm Tamoxifen Bleomycin Radiation-Protective Agents Carboplatin Mechlorethamine Etoposide Antibodies, Monoclonal RNA, Small Interfering Taxoids Iridium Radioisotopes Methotrexate Antigens, Neoplasm Antibodies, Monoclonal, Humanized Receptor, Epidermal Growth Factor Doxorubicin Prednisone Receptors, Progesterone Organoplatinum Compounds Amifostine Lomustine Tumor Suppressor Proteins Nimustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment95

Radiotherapy Dosage Radiotherapy, Image-Guided Radiotherapy Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiometry Radiation Dosage Radiotherapy, Adjuvant Combined Modality Therapy Tomography, X-Ray Computed Radiotherapy, High-Energy Dose Fractionation Radiotherapy, Computer-Assisted Treatment Outcome Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Survival Rate Early Detection of Cancer Survival Analysis Retrospective Studies Disease-Free Survival Follow-Up Studies Dose-Response Relationship, Radiation Prognosis Radiosurgery Chemotherapy, Adjuvant Chemoradiotherapy Brachytherapy Prospective Studies Dosage Forms Cranial Irradiation Kaplan-Meier Estimate Particle Accelerators Drug Administration Schedule Mastectomy, Segmental Palliative Care Tumor Burden Risk Risk Assessment Mastectomy Xenograft Model Antitumor Assays Clinical Trials as Topic Organ Sparing Treatments Multivariate Analysis Heavy Ion Radiotherapy Risk Factors Registries Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Gene Expression Profiling Feasibility Studies Radioisotope Teletherapy Positron-Emission Tomography Neoadjuvant Therapy SEER Program Sensitivity and Specificity Salvage Therapy Prostatectomy Reproducibility of Results Lymphatic Irradiation Blotting, Western Odds Ratio Predictive Value of Tests Transplantation, Heterologous Neoplasm Grading Questionnaires Lymph Node Excision Remission Induction Biopsy Laryngectomy Incidence Models, Biological Chemoradiotherapy, Adjuvant Immunohistochemistry Preoperative Care Oligonucleotide Array Sequence Analysis Molecular Targeted Therapy Treatment Failure Cohort Studies Magnetic Resonance Imaging Patient Positioning Proton Therapy Fiducial Markers Mammography Radiotherapy Setup Errors Drug Screening Assays, Antitumor Pilot Projects Polymerase Chain Reaction Postoperative Care Administration, Oral Mastectomy, Modified Radical Confidence Intervals Actuarial Analysis Logistic Models

Psychiatry and Psychology1

Phenomena and Processes29

Radiation Dosage Dose-Response Relationship, Radiation Gene Dosage Radiation Tolerance Dosage Compensation, Genetic Gene Expression Regulation, Neoplastic Time Factors Risk Dose-Response Relationship, Drug Drug Resistance, Neoplasm Genetic Predisposition to Disease Mutation Cell Survival Sensitivity and Specificity Apoptosis Odds Ratio DNA Methylation Cell Proliferation Genotype Radiation, Ionizing Cell Cycle Cell Division Cell Movement Down-Regulation Heavy Ions Genes, BRCA1 Polymorphism, Genetic Promoter Regions, Genetic Genes, p53

Disciplines and Occupations3

Radiation Oncology Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science9

Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy, Computer-Assisted Survival Rate Registries SEER Program Questionnaires Incidence

Named Groups1

Health Care38

Radiation Injuries Radiation Dosage Treatment Outcome Survival Rate Survival Analysis Retrospective Studies Disease-Free Survival Follow-Up Studies Dose-Response Relationship, Radiation Prospective Studies Kaplan-Meier Estimate Palliative Care Risk Risk Assessment Clinical Trials as Topic Age Factors Multivariate Analysis Risk Factors Registries National Cancer Institute (U.S.)Feasibility Studies SEER Program Sensitivity and Specificity Reproducibility of Results Odds Ratio Predictive Value of Tests Questionnaires Incidence Preoperative Care Treatment Failure Cohort Studies Patient Positioning Radiotherapy Setup Errors Pilot Projects Postoperative Care Confidence Intervals Actuarial Analysis Logistic Models

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Radiotherapy Dosage Radiotherapy, Image-Guided Radiotherapy Radiodermatitis Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal Radiation Injuries Radiotherapy, Intensity-Modulated Radiometry Prostatic Neoplasms Radiation Dosage Radiotherapy, Adjuvant Breast Neoplasms Combined Modality Therapy Tomography, X-Ray Computed Radiotherapy, High-Energy Dose Fractionation Radiotherapy, Computer-Assisted Lung Neoplasms Treatment Outcome Neoplasm Recurrence, Local Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Radiation Oncology Head and Neck Neoplasms Carcinoma, Squamous Cell Survival Rate Early Detection of Cancer Survival Analysis Retrospective Studies Disease-Free Survival Follow-Up Studies Dose-Response Relationship, Radiation Prognosis Neoplasms Gene Dosage Rectal Neoplasms Radiosurgery Chemotherapy, Adjuvant Chemoradiotherapy Cisplatin Brachytherapy Antineoplastic Agents Brain Neoplasms Neoplasm Metastasis Radiation Tolerance Uterine Cervical Neoplasms Dosage Compensation, Genetic Nasopharyngeal Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma Ovarian Neoplasms Neoplasm Invasiveness Stomach Neoplasms Fluorouracil Radiation-Sensitizing Agents Neoplasms, Radiation-Induced Pancreatic Neoplasms Prospective Studies Organs at Risk Colonic Neoplasms Neoplasms, Second Primary Mice, Nude Adenocarcinoma Dosage Forms Esophageal Neoplasms Gene Expression Regulation, Neoplastic Cranial Irradiation Disease Progression Kaplan-Meier Estimate Time Factors Particle Accelerators Cell Line, Tumor Drug Administration Schedule Mastectomy, Segmental Palliative Care Tumor Burden Radiation Pneumonitis Pelvic Neoplasms Prostate-Specific Antigen Tumor Markers, Biological Cancer Vaccines Neoplasm Proteins Urinary Bladder Neoplasms Risk Dose-Response Relationship, Drug Risk Assessment Survivors Hodgkin Disease Bone Neoplasms Mastectomy Vincristine Xenograft Model Antitumor Assays Clinical Trials as Topic Age Factors Organ Sparing Treatments Multivariate Analysis Drug Resistance, Neoplasm Heavy Ion Radiotherapy Laryngeal Neoplasms

No FAQ available that match "treatment of cancer radiotherapy dosage"